Log in to save to my catalogue

Rare Opportunities: CRISPR/Cas-Based Therapy Development for Rare Genetic Diseases

Rare Opportunities: CRISPR/Cas-Based Therapy Development for Rare Genetic Diseases

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6469594

Rare Opportunities: CRISPR/Cas-Based Therapy Development for Rare Genetic Diseases

About this item

Full title

Rare Opportunities: CRISPR/Cas-Based Therapy Development for Rare Genetic Diseases

Publisher

Cham: Springer International Publishing

Journal title

Molecular diagnosis & therapy, 2019-04, Vol.23 (2), p.201-222

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

Rare diseases pose a global challenge, in that their collective impact on health systems is considerable, whereas their individually rare occurrence impedes research and development of efficient therapies. In consequence, patients and their families are often unable to find an expert for their affliction, let alone a cure. The tide is turning as ph...

Alternative Titles

Full title

Rare Opportunities: CRISPR/Cas-Based Therapy Development for Rare Genetic Diseases

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6469594

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6469594

Other Identifiers

ISSN

1177-1062

E-ISSN

1179-2000

DOI

10.1007/s40291-019-00392-3

How to access this item